AI assistant
AIM ImmunoTech Inc. — Director's Dealing 2016
Jun 2, 2016
35334_dirs_2016-06-02_38605c8c-5d1b-4ea8-9aed-6940ab0c77dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2016-05-31
Reporting Person: Springate Wayne S. (Sr VP of Operations)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-05-31 | Incentive Rights | $0 | A | 13939 | Acquired | 2016-11-30 | Common Stock (13939) | Direct |
Footnotes
F1: Issued pursuant to the Hemispherx Biopharma Inc 2016 voluntary incentive stock award plan. Pursuant to the plan, the reporting person has the right to withhold a portion of their salary in exchange for the incentive right. The incentive right grants the reporting person the right to receive a number of shares of common stock based upon the market price on the day prior to election. The incentive right automatically converts into common stock on the date exercisable. The plan is described in the Issuer's annual 10K report for the year ended 12/31/15.